Myelin Oligodendrocyte Glycoprotein (MOG) (Middle Region) Peptide
MOG
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5511354
Quick Overview for Myelin Oligodendrocyte Glycoprotein (MOG) (Middle Region) Peptide (ABIN5511354)
Target
MOG
(Myelin Oligodendrocyte Glycoprotein (MOG))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- VELPCRISPG KNATGMEVGW YRPPFSRVVH LYRNGKDQDG DQAPEYRGRT
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- MOG Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
Myelin Oligodendrocyte Glycoprotein (MOG) peptide
MOG Reactivity: Human, Cow, Mouse, Pig, Rat Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
-
Background
-
The product of this gene is a membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, it is a primary target antigen involved in immune-mediated demyelination. This protein may be involved in completion and maintenance of the myelin sheath and in cell-cell communication. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alias Symbols: BTN6, BTNL11, MOGIG2, NRCLP7
Protein Size: 208 -
Gene ID
- 4340
-
NCBI Accession
- NM_001008228, NP_001008229
Target
-
You are here:
